Search results for " Small"

showing 10 items of 806 documents

The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells

2014

The TH9 subset of helper T cells was initially shown to contribute to the induction of autoimmune and allergic diseases, but subsequent evidence has suggested that these cells also exert antitumor activities. However, the molecular events that account for their effector properties are elusive. Here we found that the transcription factor IRF1 enhanced the effector function of TH9 cells and dictated their anticancer properties. Under TH9-skewing conditions, interleukin 1β (IL-1β) induced phosphorylation of the transcription factor STAT1 and subsequent expression of IRF1, which bound to the promoters of Il9 and Il21 and enhanced secretion of the cytokines IL-9 and IL-21 from TH9 cells. Further…

OvalbuminGreen Fluorescent ProteinsImmunologyMelanoma ExperimentalProto-Oncogene Proteins c-fyn3T3 cellsCell LineInterferon-gammaMicemedicineAnimalsImmunology and AllergySTAT1PhosphorylationRNA Small InterferingSTAT4Transcription factorInterleukin 3Mice KnockoutBase SequencebiologySequence Analysis RNAChemistryEffectorInterleukinsInterleukin-9Promoter3T3 CellsT-Lymphocytes Helper-InducerInterleukin-10Cell biologyMice Inbred C57BLSTAT1 Transcription Factormedicine.anatomical_structureCell culturebiology.proteinFemaleRNA InterferenceInterferon Regulatory Factor-1Nature Immunology
researchProduct

Cellular Uptake of siRNA-Loaded Nanocarriers to Knockdown PD-L1: Strategies to Improve T-cell Functions

2020

T-cells are a type of lymphocyte (a subtype of white blood cells) that play a central role in cell-mediated immunity. Currently, adoptive T-cell immunotherapy is being developed to destroy cancer cells. In this therapy, T-cells are harvested from a patient&rsquo

PD-L1Small interfering RNAT-LymphocytesLymphocytemedicine.medical_treatmentT cellImmunotherapy AdoptiveB7-H1 AntigenArticlemedicineHumansNanotechnologyRNA Small Interferinglcsh:QH301-705.5Gene knockdownnanocarriersChemistryT-cellsCancercellular uptakeGeneral MedicineImmunotherapymedicine.diseasemedicine.anatomical_structurelcsh:Biology (General)siRNACancer cellCancer researchNanocarriersadoptive immunotherapyCells
researchProduct

Decentralized Lightweight Group Key Management for Dynamic Access Control in IoT Environments

2020

Rapid growth of Internet of Things (IoT) devices dealing with sensitive data has led to the emergence of new access control technologies in order to maintain this data safe from unauthorized use. In particular, a dynamic IoT environment, characterized by a high signaling overhead caused by subscribers' mobility, presents a significant concern to ensure secure data distribution to legitimate subscribers. Hence, for such dynamic environments, group key management (GKM) represents the fundamental mechanism for managing the dissemination of keys for access control and secure data distribution. However, existing access control schemes based on GKM and dedicated to IoT are mainly based on ce…

PROTOCOLSCRYPTOGRAPHYComputer Networks and CommunicationsComputer scienceGROUP COMMUNICATIONKey distributionCore networkRESEAU INFORMATIQUEAccess control02 engineering and technologySCALABILITYTECHNOLOGIE SANS FIL[SPI]Engineering Sciences [physics][INFO.INFO-NI]Computer Science [cs]/Networking and Internet Architecture [cs.NI]TELECOMMUNICATIONForward secrecy0202 electrical engineering electronic engineering information engineeringRekeyingINTERNET OF THINGSElectrical and Electronic EngineeringINTERNETSECURITEDYNAMIC ENVIRONMENTSECURITYIOTTRAITEMENT DES DONNEESbusiness.industryKey distribution center020206 networking & telecommunicationsWIRELESS SENSOR NETWORKSRESEAU DE TELECOMMUNICATIONSGROUP KEY MANAGEMENTINFORMATIQUECommunication in small groupsScalabilityARCHITECTURE CLIENT-SERVEURbusinessCOMPUTER ARCHITECTUREACCESS CONTROLComputer network
researchProduct

Multi-Functional Nanogels for Tumor Targeting and Redox-Sensitive Drug and siRNA Delivery

2016

(1) Background: A new family of nanosystems able to discern between normal and tumor cells and to release a therapeutic agent in controlled way were synthetized by e-beam irradiation. This technique permits to obtain biocompatible, sterile, carboxyl-functionalized polyvinylpyrrolidone (PVP-co-acrylic acid) nanogels (NGs); (2) Methods: Here, we performed a targeting strategy based on the recognition of over-expressed proteins on tumor cells, like the folate receptor. The selective targeting was demonstrated by co-culture studies and flow cytometry analysis, using folate conjugated NGs. Moreover, nanoparticles were conjugated to a chemotherapeutic drug or to a pro-apoptotic siRNA through a gl…

PVPPharmaceutical ScienceNanogels02 engineering and technologyPharmacology01 natural sciencesAntioxidantsAnalytical Chemistryfolate-targetingPolyethylene GlycolsNanogelchemistry.chemical_compoundMiceRNA interferenceNeoplasmsDrug DiscoveryFluorescence microscopePolyethyleneimineRNA Small InterferingCytotoxicitymedicine.diagnostic_testPovidone021001 nanoscience & nanotechnologyControlled releaseCell biologyChemistry (miscellaneous)Folate receptorMolecular Medicinee-beamGSH-responsive release0210 nano-technologyOxidation-Reduction010402 general chemistrydoxorubicinArticleFlow cytometryFolic AcidCell Line TumormedicineAnimalsHumansPhysical and Theoretical ChemistryParticle SizeOrganic ChemistryGlutathione0104 chemical scienceschemistryPVP; nanogels; e-beam; folate-targeting; doxorubicin; siRNA; GSH-responsive releasesiRNACancer cellNIH 3T3 CellsNanoparticlesSettore CHIM/07 - Fondamenti Chimici Delle TecnologieFolic Acid TransportersHeLa CellsMolecules
researchProduct

Large- and small-mammal distribution patterns and chronostratigraphic boundaries from the Late Pliocene to the Middle Pleistocene of the Italian peni…

2007

Abstract Over the last 50 years the studies on terrestrial mammals of the Italian peninsula have provided a large volume of data and a more detailed knowledge of faunal events during the Late Pliocene and Quaternary. Moreover geological, sedimentological, palynological and magnetostratigraphical investigations on the Pliocene–Pleistocene continental sedimentary basins have yielded the possibility of a detailed calibration of the faunal successions. Thus, palaeontologists have been able to reconstruct faunal sequences and to propose biochronological scales based on large and small mammals, respectively. In the present contribution an integration of the two biochronological scales is proposed…

Palynologygeographygeography.geographical_feature_categoryPleistocenechronostratigraphical boundariesSmall mammalSedimentary basinIntegrated approachLate Pllioce-Middle PleistoceneLarge and small mammals; distribution patterns; chronostratigraphical boundaries; Late Pllioce-Middle Pleistocene; Italian peninsuladistribution patternsSequence (geology)PaleontologyPeninsulaPleistocene mammals bio-chronology ItalyQuaternaryGeologyLarge and small mammalsItalian peninsulaEarth-Surface Processes
researchProduct

Expression of T-cadherin in tumor cells influences invasive potential of human hepatocellular carcinoma

2006

Overexpression of T-cadherin (T-cad) transcripts occurs in approximately 50% of human hepatocellular carcinomas (HCCs). To elucidate T-cad functions in HCC, we examined T-cad protein expression in normal and tumoral human livers and hepatoma cell lines and investigated its influence on invasive potential of HCC using RNA interference silencing of T-cad expression in Mahlavu cells. Whereas T-cad expression was restricted to endothelial cells (EC) from large blood vessels in normal livers, it was up-regulated in sinusoidal EC from 8/15 invasive HCCs. Importantly, in three of them (38%) T-cad was detected in tumor cells within regions in which E-cadherin expression was absent. Among six hepato…

Pathologymedicine.medical_specialtyCarcinoma HepatocellularTranscription GeneticLiver cytologyCell Culture TechniquesMotilityBiologyTransfectionBiochemistryRNA interferenceCell MovementCell Line TumorGeneticsmedicineGene silencingAnimalsHumansNeoplasm Invasivenesscardiovascular diseasesRNA Small InterferingMolecular BiologyDNA PrimersWound Healingprimary tumors cadherin switch cell invasion hepatoma cell lines RNA interferenceLiver NeoplasmsEndothelial CellsTransfectionHCCSFibroblastsCadherinsdigestive system diseasesT-cadherinLiverCell cultureCancer researchHepatocytesRabbitsCell DivisionBiotechnology
researchProduct

Neuroendocrine Neoplasms (NENs)

2021

Neuroendocrine neoplasms (NENs) represent a rare and heterogeneous group of malignancies which can develop in many different sites of our body. They originate from the cells of the diffuse neuroendocrine system. Gastroenteropancreatic NENs were classified in four categories, including NETs G1 (WD with 20% Ki-67), and NECs (PD with >20% Ki-67) in accordance with the 2019 WHO classification (IARC WHO Classification of the digestive system tumors, on 11th July 2019). Lung NENs, in accordance with the latest WHO classification, 2015 edition, are distinguished in small cell lung cancer (SCLC), large cell neuroendocrine carcinoma (LCNEC), atypical carcinoid (AC), and typical carcinoid (TC).

Pathologymedicine.medical_specialtyHeterogeneous groupLungmedicine.anatomical_structurebusiness.industryMedicineTypical carcinoidNon small cellLarge-cell neuroendocrine carcinomaWho classificationbusinessAtypical carcinoid
researchProduct

Antiamphiphysin-positive stiff-person syndrome associated with small cell lung cancer

2006

The paraneoplastic amphiphysin(+) stiff-person syndrome (SPS) has so far only been described in women with breast adenocarcinoma. Here, we describe the rare case of a female patient with antiamphiphysin(+) SPS due to small cell cancer of the lung.

Pathologymedicine.medical_specialtyLung NeoplasmseducationNerve Tissue ProteinsStiff-Person SyndromeBreast AdenocarcinomaSmall-cell carcinomafluids and secretionsmedicineCarcinomaHumansCarcinoma Small CellLung cancerAutoantibodiesLungElectromyographybusiness.industryfungiRespiratory diseaseMiddle Agedequipment and suppliesmedicine.diseasemedicine.anatomical_structureNeurologyAmphiphysinFemaleNeurology (clinical)businessStiff person syndromeMovement Disorders
researchProduct

Treatment of advanced non-small cell lung cancer: chemotherapy with or without cisplatin?

2006

Pathologymedicine.medical_specialtyLung Neoplasmsmedicine.medical_treatmentPlatinum Compounds.Medical OncologyCarboplatinchemistry.chemical_compoundCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineCarcinomaHumansLung cancerNeoplasm StagingCisplatinChemotherapybusiness.industryRespiratory diseasePlatinum compoundsHematologyPrognosismedicine.diseaseCarboplatinOncologychemistryCancer researchNon small cellCisplatinbusinessmedicine.drug
researchProduct

Differential Gene Expression of Medullary Thyroid Carcinoma Reveals Specific Markers Associated with Genetic Conditions

2013

Maliszewska, Agnieszka et al.

Pathologymedicine.medical_specialtyendocrine system diseasesInheritance PatternsMultiple endocrine neoplasia type 2ApoptosisBiologyGermlinePathology and Forensic MedicineThyroid carcinomaAntigens CDCell Line TumormedicineBiomarkers TumorGene silencingCluster AnalysisHumansGenetic Predisposition to DiseaseAC133 AntigenGene SilencingThyroid NeoplasmsRNA Small InterferingGlycoproteinsRegulation of gene expressionTissue microarrayReverse Transcriptase Polymerase Chain ReactionGene Expression ProfilingWnt signaling pathwaymedicine.diseaseImmunohistochemistryCarcinoma NeuroendocrineGene expression profilingGene Expression Regulation NeoplasticGene Knockdown TechniquesCancer researchPeptides
researchProduct